Evidence map›Paper›PMID 37067297›Full record

ArticleCardiovascular research2023

Lem2 is essential for cardiac development by maintaining nuclear integrity.

Jacob A Ross, Nathaly Arcos-Villacis, Edmund Battey, Cornelis Boogerd, Constanza Avalos Orellana, Emilie Marhuenda, Pamela Swiatlowska, Didier Hodzic, Fabrice Prin, Tim Mohun and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Cardiovascular research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Altered Expression ofInternational journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 4 countries.

Jacob A RossBritish Heart Foundation Centre of Research Excellence, School of Cardiovascular & Metabolic Medicine & Sciences, Faculty of Life Sciences & Medicine, King's College London, James Black Centre, 125 Coldharbour Lane, London SE5 9NU, UK.
Nathaly Arcos-VillacisBritish Heart Foundation Centre of Research Excellence, School of Cardiovascular & Metabolic Medicine & Sciences, Faculty of Life Sciences & Medicine, King's College London, James Black Centre, 125 Coldharbour Lane, London SE5 9NU, UK.
Edmund BatteyBritish Heart Foundation Centre of Research Excellence, School of Cardiovascular & Metabolic Medicine & Sciences, Faculty of Life Sciences & Medicine, King's College London, James Black Centre, 125 Coldharbour Lane, London SE5 9NU, UK.
Cornelis BoogerdHubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), University Medical Center Utrecht, Utrecht 3584 CT, The Netherlands.
Constanza Avalos OrellanaBritish Heart Foundation Centre of Research Excellence, School of Cardiovascular & Metabolic Medicine & Sciences, Faculty of Life Sciences & Medicine, King's College London, James Black Centre, 125 Coldharbour Lane, London SE5 9NU, UK.
Emilie MarhuendaDivision of Bioengineering, School of Engineering and Materials Science, Queen Mary University of London, London E1 4NS, UK.
Pamela SwiatlowskaDivision of Bioengineering, School of Engineering and Materials Science, Queen Mary University of London, London E1 4NS, UK.
Didier HodzicDepartment of Developmental Biology, Washington University School of Medicine, 660S. Euclid Avenue, St Louis, MO 63110, USA.
Fabrice PrinCrick Advanced Light Microscopy Facility, The Francis Crick Institute, London NW1 1AT, UK.
Tim MohunCrick Advanced Light Microscopy Facility, The Francis Crick Institute, London NW1 1AT, UK.
Norman CatibogBritish Heart Foundation Centre of Research Excellence, School of Cardiovascular & Metabolic Medicine & Sciences, Faculty of Life Sciences & Medicine, King's College London, James Black Centre, 125 Coldharbour Lane, London SE5 9NU, UK.
Olga TapiaDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA.
Larry GeraceDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA.
Thomas IskratschDivision of Bioengineering, School of Engineering and Materials Science, Queen Mary University of London, London E1 4NS, UK.
Ajay M ShahBritish Heart Foundation Centre of Research Excellence, School of Cardiovascular & Metabolic Medicine & Sciences, Faculty of Life Sciences & Medicine, King's College London, James Black Centre, 125 Coldharbour Lane, London SE5 9NU, UK.
Matthew J StroudBritish Heart Foundation Centre of Research Excellence, School of Cardiovascular & Metabolic Medicine & Sciences, Faculty of Life Sciences & Medicine, King's College London, James Black Centre, 125 Coldharbour Lane, London SE5 9NU, UK.ORCID 0000-0002-3337-6851
King's College London · GBQueen Mary University of London · GBScripps Research Institute · USThe Francis Crick Institute · GBRoyal Netherlands Academy of Arts and Sciences · NLWashington University in St. Louis · US

Funding

STRUCTURE AND FUNCTIONS OF THE NUCLEAR ENVELOPER01GM028521 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI GERACE, LARRY R. · 1985 to 2020
$7.0M
Biotechnology and Biological Sciences Research Council BB/S001123/1British Heart Foundation CH/1999001/11735British Heart Foundation FS/17/57/32934British Heart Foundation PG/20/6/34835British Heart Foundation RE/18/2/34213Medical Research Council MR/S023593/1NIGMS NIH HHS R01 GM028521
6 · The paper itself

Abstract

aimsNuclear envelope integrity is essential for the compartmentalization of the nucleus and cytoplasm. Importantly, mutations in genes encoding nuclear envelope (NE) and associated proteins are the second highest cause of familial dilated cardiomyopathy. One such NE protein that causes cardiomyopathy in humans and affects mouse heart development is Lem2. However, its role in the heart remains poorly understood. METHODS AND

resultsWe generated mice in which Lem2 was specifically ablated either in embryonic cardiomyocytes (Lem2 cKO) or in adult cardiomyocytes (Lem2 iCKO) and carried out detailed physiological, tissue, and cellular analyses. High-resolution episcopic microscopy was used for three-dimensional reconstructions and detailed morphological analyses. RNA-sequencing and immunofluorescence identified altered pathways and cellular phenotypes, and cardiomyocytes were isolated to interrogate nuclear integrity in more detail. In addition, echocardiography provided a physiological assessment of Lem2 iCKO adult mice. We found that Lem2 was essential for cardiac development, and hearts from Lem2 cKO mice were morphologically and transcriptionally underdeveloped. Lem2 cKO hearts displayed high levels of DNA damage, nuclear rupture, and apoptosis. Crucially, we found that these defects were driven by muscle contraction as they were ameliorated by inhibiting myosin contraction and L-type calcium channels. Conversely, reducing Lem2 levels to ∼45% in adult cardiomyocytes did not lead to overt cardiac dysfunction up to 18 months of age.

conclusionsOur data suggest that Lem2 is critical for integrity at the nascent NE in foetal hearts, and protects the nucleus from the mechanical forces of muscle contraction. In contrast, the adult heart is not detectably affected by partial Lem2 depletion, perhaps owing to a more established NE and increased adaptation to mechanical stress. Taken together, these data provide insights into mechanisms underlying cardiomyopathy in patients with mutations in Lem2 and cardio-laminopathies in general.

Indexed as

Nuclear EnvelopeNuclear ProteinsAnimalsDNA DamageHeartHumansMembrane ProteinsMiceMutationMyocytes, CardiacLem2 protein, mouseMembrane ProteinsNuclear ProteinsCardiac developmentHeart failureLaminopathyLINC complexNuclear Envelope

Identifiers

PMID37067297
PMCPMC10478753
OpenAlexW4366083023

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.